3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Plasmacytoma
1
Nasopharyngeal Carcinoma
1
Meningeal Carcinomatosis
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Glioma
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Interventions
Rituximab
14
Cyclophosphamide
10
Magnetic Resonance Spectroscopy
8
Lenalidomide
8
venetoclax
6
Specimen Handling
6
obinutuzumab
5
ibrutinib
5
Prednisone
5
Biopsy
5
zanubrutinib
4
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Vincristine
4
CT-P10
4
polatuzumab vedotin
3
orelabrutinib
3
Mycophenolic Acid
3
Doxorubicin
3
Cyclosporine
3
Bendamustine Hydrochloride
3
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Busulfan
2
voruciclib
1
treosulfan
1
tafasitamab
1
prednylidene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Immunotherapy, Adoptive
×
90 days
×
Clear all
No trials found.